These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey. Nakajima M; Adachi I; Ueda M Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814 [TBL] [Abstract][Full Text] [Related]
4. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers]. Kitamura K; Ogata R Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831 [No Abstract] [Full Text] [Related]
5. Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders. Marin J Gen Pharmacol; 1988; 19(3):295-306. PubMed ID: 2458295 [TBL] [Abstract][Full Text] [Related]
6. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle]. Xiao HJ; Liu JH Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335 [TBL] [Abstract][Full Text] [Related]
7. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells. Matsuoka T; Nishizaki T; Nomura T Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells. Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869 [TBL] [Abstract][Full Text] [Related]
9. [The role of Ca2+ in the pathogenesis of epilepsy. Calcium antagonists--a new class of anticonvulsants]. Glebov RN; Karpova MN Patol Fiziol Eksp Ter; 1990; (3):57-61. PubMed ID: 2169039 [No Abstract] [Full Text] [Related]
10. Effects of anisodamine and dauricine on proliferation, DNA synthesis, and calcium influx in bovine anterior cerebral arterial smooth muscle cells in culture. Zeng GQ; Rui YC Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):308-11. PubMed ID: 1807078 [TBL] [Abstract][Full Text] [Related]
15. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Triggle DJ Cleve Clin J Med; 1992; 59(6):617-27. PubMed ID: 1330367 [TBL] [Abstract][Full Text] [Related]
16. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles. Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820 [TBL] [Abstract][Full Text] [Related]
17. [Mechanism of action of calcium antagonists in the treatment of vascular diseases]. Mayerhofer S Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066 [TBL] [Abstract][Full Text] [Related]
18. [Nervous disease & Ca antagonist]. Otomo E No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488 [No Abstract] [Full Text] [Related]
19. Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers. Schachter M Int J Cardiol; 1997 Dec; 62 Suppl 2():S85-90. PubMed ID: 9488199 [TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists]. Faulhaber HD Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075 [No Abstract] [Full Text] [Related] [Next] [New Search]